x

Coronavirus

British Experts Slam US for Hoarding Remdesivir

LONDON — Some British experts have slammed the U.S. decision to snap up nearly the entire global supply of remdesivir, the only drug licensed so far to treat COVID-19.

Ohid Yaqub, a senior lecturer at the University of Sussex called it “disappointing news” in a statement.

“It so clearly signals an unwillingness to cooperate with other countries and the chilling effect this has on international agreements about intellectual property rights,” Yaqub said.

The U.S. government announced Tuesday that President Donald Trump had struck “an amazing deal” to buy the remdesivir drug for Americans, made by Gilead. The Department of Health and Human Services said Trump has secured 500,000 treatments of the drug through September, representing 100% of Gilead’s July production capacity and 90% of its capacity in August and September.

In earlier stages of the pandemic, the U.S. refused to export pre-ordered masks to other countries, including Canada.

RELATED

LONDON (AP) — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

WASHINGTON (AP) — Trucks carrying badly needed aid for the Gaza Strip rolled across a newly built U.

FLUSHING, NY – Pericly (Perry) Athanasios Jonson, 57, of Flushing, New York, passed away on May 13.

ATHENS - As he did with Albania over the jailing of ethnic Greek Fredi Beleri after winning a mayoral election, Prime Minister Kyriakos Mitsotakis said Greece will stymie North Macedonia’s hopes of joining the European Union if a new government insists on calling it Macedonia.

ATHENS - In a case stalled for years, a prosecutor has asked a court to convict the founder of the Folli Follie jewelry and accessory company Dimitris Koutsoulioutsos and his son Tzortis on a range of changes including fraud.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.